WallStSmart
NNVC

NanoViricides Inc

NYSE MKT: NNVC · HEALTHCARE · BIOTECHNOLOGY

$1.24
+1.64% today

Updated 2026-04-30

Market cap
$26.99M
P/E ratio
P/S ratio
EPS (TTM)
$-0.49
Dividend yield
52W range
$1 – $2
Volume
0.2M

NanoViricides Inc (NNVC) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-1.82M$-2.33M$-2.55M$-2.68M$-2.05M$-4.51M$-4.22M$-5.80M$-6.33M$-6.21M$-6.83M$-7.90M$-7.78M$-6.80M$-6.67M$-8.21M$-5.89M$-5.67M$-6.32M$-8.48M
Capital expenditures$2148.00$26173.00$121173.00$752805.00$744779.00$194042.00$58552.00$64931.00$5.23M$6.76M$476368.00$164978.00$241822.00$73794.00$8638.00$238764.00$324348.00$151712.00$156560.00$56964.00
Depreciation$44555.00$36301.00$13472.00$12290.00$90289.00$527742.00$219653.00$219651.00$212009.00$302738.00$659545.00$662954.00$680058.00$695911.00$699724.00$704538.00$723325.00$747529.00$759014.00$743805.00
Stock-based comp$27062.00$7044.00$1.22T$982867.00$445044.00$2.12M$1.16M$1.23M$1.60M$791164.00$532320.00$559398.00$405594.00$338418.00$214179.00$222185.00$223347.00
Free cash flow$-1.83M$-2.36M$-2.67M$-3.43M$-2.79M$-4.70M$-4.28M$-5.86M$-11.56M$-12.97M$-7.31M$-8.06M$-8.02M$-6.88M$-6.67M$-8.45M$-6.22M$-5.82M$-6.47M$-8.54M
Investing cash flow$-2148.00$-126173.00$-101173.00$-744779.00$-194042.00$-58552.00$-1.06M$-5.23M$-5.76M$-476368.00$-164978.00$-241822.00$-73794.00$-8638.00$-238764.00$-324348.00$-151712.00$-156560.00$-56964.00
Financing cash flow$4.33M$920000.00$2.50M$4.23M$8.06M$6.97M$9.33M$6.51M$34.34M$6743.00$313000.00$-1.00M$4.61M$2.35M$17.83M$15.26M$-234716.00$-94788.00$3.12M$5.30M
Dividends paid$79.47M$90.11M$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$5.05M$-351740.00$22.77M$-5.23M$-7.31M$-9.06M$-8.02M$-4.53M$11.15M